Agilent Technologies (NYSE:A) Price Target Raised to $175.00

by · The Markets Daily

Agilent Technologies (NYSE:A – Free Report) had its price target lifted by Barclays from $150.00 to $175.00 in a research note published on Thursday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock.

Other equities analysts have also recently issued research reports about the stock. HSBC cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Piper Sandler began coverage on Agilent Technologies in a research note on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price on the stock. Morgan Stanley increased their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Royal Bank Of Canada boosted their target price on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $170.33.

View Our Latest Research Report on Agilent Technologies

Agilent Technologies Price Performance

NYSE:A opened at $154.47 on Thursday. The firm has a market capitalization of $43.63 billion, a price-to-earnings ratio of 30.41, a P/E/G ratio of 2.65 and a beta of 1.25. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.62 and a current ratio of 2.05. The stock has a fifty day moving average of $140.30 and a 200 day moving average of $127.04. Agilent Technologies has a 52-week low of $108.35 and a 52-week high of $163.75.

Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.Agilent Technologies’s revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, research analysts expect that Agilent Technologies will post 6.2 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilent Technologies

Large investors have recently added to or reduced their stakes in the company. SHP Wealth Management purchased a new position in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies during the fourth quarter worth about $26,000. Navalign LLC bought a new stake in shares of Agilent Technologies in the fourth quarter worth about $27,000. Markowski Investments purchased a new position in Agilent Technologies during the 2nd quarter valued at about $27,000. Finally, MV Capital Management Inc. purchased a new position in Agilent Technologies during the 4th quarter valued at about $28,000.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

  • Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
  • Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
  • Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
  • Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

About Agilent Technologies

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Read More